PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 1984The Journal of Urology46 citations

In situ Management of Renal Tumors: Renal Cell Carcinoma and Transitional Cell Carcinoma

View Full Paper
FMFray F. MarshallPWPatrick C. Walsh

Key Points

Key points are not available for this paper at this time.

Abstract

In the last 8 years 15 patients with malignant neoplasms in functionally solitary kidneys underwent in situ excision of the tumor with preservation of renal parenchyma. Of 10 patients with renal cell carcinoma 8 underwent partial nephrectomy, 1 had a central wedge resection and 1 had enucleation of 3 tumors. After followup of 6 months to 4.7 years 6 patients are free of disease. One patient died of metastatic cancer and 1 of cardiovascular disease. Of 5 patients with transitional cell carcinoma of the kidney (including 2 with parenchymal invasion) 2 underwent partial nephrectomy and 3 underwent extensive resection of renal pelvic lesions. After followup of 6 months to 7 years 2 patients are alive, 2 died of metastatic disease and 1 died of metastatic bladder carcinoma. Only 1 of the 5 patients had locally recurrent tumor. These data demonstrate the efficacy of in situ management of renal tumors in selected patients with solitary kidneys or compromised renal function.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marshall et al. (1984) studied this question.

synapsesocial.com/papers/6a897900055af99351621384https://doi.org/10.1016/s0022-5347(17)50799-5
Ask AI
Helpful
Bookmark
Share
View Full Paper